AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Feb 6, 2017
30071_dirs_2017-02-06_e958bdef-4d9d-4c7f-8cf1-33028f15f99f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-02-03
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-03 | ResMed Common Stock | M | 6365 | $27.58 | Acquired | 84261 | Direct |
| 2017-02-03 | ResMed Common Stock | S | 6365 | $67.16 | Disposed | 77896 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-03 | ResMed Common Stock Options | $27.58 | M | 6365 | Disposed | 2018-11-16 | ResMed Common Stock (6365) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Represents date options first became exercisable. Options vest 1/4 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29